NEUP Neuphoria Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Sep 18, 2026
$3.47
· of 52w range
· above low
· to high
$3.1952w low
$21.4052w high
Market Cap (MRQ)
$19M
P/E
-1.1
EPS
$-3.06
Revenue
$1M
your badges
52W Range
$3–$21
Analyst Rating
HOLD
Price Target
$7
P/E
-1.1
ROE
-49.5%
Net Profit Margin
-1145.7%
Your badge strip is empty — pin a metric anywhere on this page.
NEUP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.47
Market Cap (MRQ)
$19M
P/E
-1.1
EPS
$-3.06
Revenue
$1M
ROE
-49.5%
52W Range
$3–$21
NEUP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Dec. 24, 2024 | 1-for-12 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1M2025-06-30 → 2026-06-30
EPS$-3.062023-06-30 → 2026-06-30
Net margin-1145.7%2025-06-30 → 2026-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NEUP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.15Y avg ≈-10.9 | ≈-10.9 | · | · | |
| P/S | 16.0 | · | · | · | |
| P/B (MRQ) | 0.85Y avg ≈418.8 | ≈418.8 | · | · | |
| Price / Cash Flow | -1.55Y avg ≈-438.3 | ≈-438.3 | · | · | |
| Price / Tangible Book (MRQ) | 0.95Y avg ≈2196.4 | ≈2196.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NEUP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -1401.1% | · | · | · | |
| EBITDA Margin | -1401.1% | · | · | · | |
| Pretax Margin | -1157.5% | · | · | · | |
| Net Profit Margin | -1145.7% | · | · | · | |
| ROA | -46.9%5Y avg ≈-34.5% | ≈-34.5% | · | · | |
| ROE | -49.5%5Y avg ≈-46.4% | ≈-46.4% | · | · | |
| ROIC | -66.2%5Y avg ≈-56.8% | ≈-56.8% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NEUP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 27.85Y avg ≈11.6 | ≈11.6 | · | · | |
| Quick Ratio | 27.35Y avg ≈11.3 | ≈11.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | NEUP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -92.5% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | NEUP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | |
| Receivables Turnover | 2.8 | · | · | · | |
| Revenue / Employee | ≈$167.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-38.7%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2026 | Nov 12, 2026 | $-0.09 | $-1.47 | 93.9% |
| June 30, 2026 | $-0.95 | $-0.57 | -66.3% | |
| March 31, 2026 | May 15, 2026 | $-0.09 | $-0.99 | 90.9% |
| Dec. 31, 2025 | $-0.77 | $-1.49 | 48.4% | |
| Sept. 30, 2025 | $-4.41 | $-1.35 | -225.9% | |
| June 30, 2025 | $-5.79 | $-2.12 | -173.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue | $1M | $16M | |
| R&D Expense | · | $9M | |
| SG&A Expense | $7M | $8M | |
| Operating Expenses | $18M | $17M | |
| Operating Income | $-16M | $-1M | |
| Interest Income | $665.6K | $166.5K | |
| Other Non-op | $3M | $291.1K | |
| Pretax Income | $-14M | $-838.0K | |
| Income Tax | $-139.2K | $-468.4K | |
| Net Income | $-13M | $-369.6K | |
| EPS (Basic) | $-3.06 | $-0.23 | |
| EPS (Diluted) | $-3.06 | $-0.23 | |
| Shares (Basic) | 4,395,776 | 1,622,924 | |
| Shares (Diluted) | 4,395,776 | 1,622,924 | |
| EBITDA | $-16M | $-1M |
Balance Sheet
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Cash & Equivalents | $20M | $14M | |
| Receivables | $813.4K | $11.9K | |
| Prepaid Expense | $389.8K | $740.2K | |
| Current Assets | $21M | $15M | |
| PP&E (Net) | · | $2.8K | |
| Goodwill | $3M | $9M | |
| Intangibles | $4M | $5M | |
| Total Assets | $29M | $29M | |
| Accounts Payable | $385.6K | $1M | |
| Current Liabilities | $756.6K | $4M | |
| Deferred Tax | $355.9K | $495.1K | |
| Total Liabilities | $4M | $10M | |
| Common Stock | $54 | $19 | |
| Paid-in Capital | $218M | $200M | |
| Retained Earnings | $-192M | $-178M | |
| AOCI | $-2M | $-3M | |
| Stockholders' Equity | $25M | $19M | |
| Liabilities + Equity | $29M | $29M | |
| Shares Outstanding | 5,411,334 | 1,978,460 |
Cash Flow
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| D&A | $663.0K | $662.9K | |
| Stock-based Comp | $351.6K | $163.8K | |
| Deferred Tax | $-139.2K | $-468.4K | |
| Operating Cash Flow | $-12M | $77.2K | |
| Stock Issued | $18M | $2M | |
| Net Stock Activity | $18M | $2M | |
| Financing Cash Flow | $18M | $2M | |
| Net Change in Cash | $6M | $2M |
Profitability
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Operating Margin | -1401.1% | -7.2% | |
| Net Margin | -1145.7% | -2.4% | |
| Pretax Margin | -1157.5% | -5.3% | |
| EBITDA Margin | -1401.1% | -7.2% | |
| ROA | -46.9% | -1.3% | |
| ROE | -49.5% | -2.3% | |
| ROIC | -66.2% | -2.6% |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Current Ratio | 27.8 | 3.6 | |
| Quick Ratio | 27.3 | 3.4 |
Efficiency
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.6 | |
| Receivables Turnover | 2.8 | 225.4 |
Per Share
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Book Value / Share | $4.55 | $9.60 | |
| Revenue / Share | $0.27 | $9.64 | |
| Cash Flow / Share | $-2.81 | $0.05 | |
| Cash / Share | $3.67 | $7.18 | |
| EPS (TTM) | $-3.06 | $-0.23 |
Growth Rates
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue YoY | -92.5% | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue TTM | $1M | $16M | |
| Net Income TTM | $-13M | $-400.0K | |
| Market Cap | $24M | $14M | |
| P/E | -1.4 | -30.9 | |
| P/S | 20.1 | 0.9 | |
| P/B | 1.0 | 0.7 | |
| P / Tangible Book | 1.4 | 2.5 | |
| P / Cash Flow | -1.9 | 181.9 | |
| Earnings Yield | -70.0% | -3.2% |
Income Statement
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $-13.3K | $15M | $662.7K | |
| R&D Expense | · | · | $697.7K | $4M | $4M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $1M | $3M | |
| Operating Expenses | $7M | $1M | $4M | $6M | $6M | $3M | $4M | |
| Operating Income | $-6M | $-1M | $-4M | $-6M | $-6M | $12M | $-4M | |
| Interest Income | $170.1K | $186.2K | $167.3K | $142.0K | $87.0K | $12.7K | $30.6K | |
| Other Non-op | $586.7K | $671.8K | $6M | $-4M | $-3M | $-796.2K | $2M | |
| Pretax Income | $-5M | $-539.9K | $2M | $-10M | $-9M | $11M | $-2M | |
| Income Tax | $-34.8K | $-34.8K | $-34.8K | $-34.8K | $-266.6K | $-81.2K | $11.6K | |
| Net Income | $-5M | $-505.1K | $2M | $-10M | $-9M | $11M | $-2M | |
| EPS (Basic) | $1.03 | $-0.09 | $0.41 | $-4.41 | $-4.93 | $6.55 | $-1.23 | |
| EPS (Diluted) | $2.21 | $-0.09 | $-0.77 | $-4.41 | $-4.37 | $6.55 | $-1.79 | |
| Shares (Basic) | · | 5,411,244 | 4,536,235 | 2,246,066 | · | 1,719,073 | 1,575,244 | |
| Shares (Diluted) | · | 5,411,244 | 4,536,235 | 2,246,066 | · | 1,719,073 | 1,575,244 | |
| EBITDA | · | $-1M | $-4M | $-6M | · | $12M | $-4M |
Balance Sheet
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $19M | $22M | $14M | $14M | $17M | $4M | |
| Receivables | $813.4K | $2M | $1M | $1.8K | $11.9K | $24.6K | $35.6K | |
| Prepaid Expense | $389.8K | $611.9K | $27.0K | $222.3K | $740.2K | $20.9K | $18.5K | |
| Current Assets | $21M | $22M | $23M | $14M | $15M | $17M | $4M | |
| PP&E (Net) | · | · | · | $2.6K | $2.8K | $1.6K | $1.7K | |
| Goodwill | $3M | $9M | $9M | $9M | $9M | $8M | $8M | |
| Intangibles | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $29M | $35M | $37M | $27M | $29M | $31M | $18M | |
| Accounts Payable | $385.6K | $627.2K | $520.7K | $1M | $1M | $745.3K | $2M | |
| Current Liabilities | $756.6K | $2M | $3M | $5M | $4M | $2M | $2M | |
| Capital Leases | · | · | · | · | · | $19.3K | $49.8K | |
| Deferred Tax | $355.9K | $390.7K | $425.5K | $460.3K | $495.1K | $761.7K | $842.9K | |
| Other Non-current Liabilities | · | · | · | · | · | $3.6K | $3.4K | |
| Total Liabilities | $4M | $5M | $7M | $15M | $10M | $5M | $4M | |
| Common Stock | $54 | $54 | $54 | $23 | $19 | $19 | $16 | |
| Paid-in Capital | $218M | $218M | $218M | $204M | $200M | $199M | $198M | |
| Retained Earnings | $-192M | $-187M | $-186M | $-188M | $-178M | $-169M | $-181M | |
| AOCI | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | |
| Stockholders' Equity | $25M | $29M | $30M | $13M | $19M | $26M | $14M | |
| Liabilities + Equity | $29M | $35M | $37M | $27M | $29M | $31M | $18M | |
| Shares Outstanding | 5,411,334 | 5,377,329 | 5,377,329 | 2,357,613 | 1,978,460 | 1,853,966 | 1,628,659 |
Cash Flow
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| D&A | $165.7K | $165.7K | $165.8K | $165.8K | $165.6K | $165.4K | $166.1K | |
| Stock-based Comp | $76.3K | $70.3K | $93.7K | $111.3K | $98.3K | $19.7K | $19.1K | |
| Restructuring | · | $42.4K | $1M | · | · | · | · | |
| Operating Cash Flow | $1M | $-3M | $-6M | $-4M | $-4M | $11M | $-3M | |
| Stock Issued | $0 | $0 | $15M | $3M | $704.7K | $823.6K | $0 | |
| Net Stock Activity | · | · | · | $3M | · | · | · | |
| Financing Cash Flow | $0 | $0 | $15M | $3M | $704.7K | $1M | $-111.6K | |
| Net Change in Cash | $424.9K | $-3M | $9M | $-560.5K | $-3M | $13M | $-4M |
Profitability
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | 79.8% | -558.8% | |
| Net Margin | · | · | · | · | · | 75.1% | -293.2% | |
| Pretax Margin | · | · | · | · | · | 74.5% | -291.5% | |
| EBITDA Margin | · | · | · | · | · | 79.8% | -558.8% | |
| ROA | · | -1.5% | 6.8% | -39.4% | · | 73.3% | -21.4% | |
| ROE | · | -1.8% | 8.6% | -67.0% | · | 86.6% | -28.3% | |
| ROIC | · | -3.9% | -13.9% | -45.0% | · | 46.4% | -27.1% |
Liquidity & Solvency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 14.3 | 9.0 | 2.7 | · | 11.0 | 2.1 | |
| Quick Ratio | · | 13.9 | 9.0 | 2.7 | · | 11.0 | 2.1 |
Efficiency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 1.0 | 0.1 | |
| Receivables Turnover | · | · | · | · | · | 1219.9 | 37.3 |
Per Share
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $5.47 | $5.52 | $5.31 | · | $14.02 | $8.44 | |
| Revenue / Share | · | · | · | · | · | $8.73 | $0.42 | |
| Cash Flow / Share | · | · | · | $-1.69 | · | · | · | |
| Cash / Share | · | $3.62 | $4.12 | $5.79 | · | $9.19 | $2.67 | |
| EPS (TTM) | · | $-9.64 | $-3.00 | $-4.02 | · | $-6.34 | $-15.72 |
Valuation (TTM)
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-17M | $-6M | $-9M | · | $6M | $-8M | |
| Market Cap | · | $22M | $21M | $28M | · | $11M | $6M | |
| P/E | · | -0.4 | -1.3 | -2.9 | · | -0.9 | -0.2 | |
| P/B | · | 0.7 | 0.7 | 2.2 | · | 0.4 | 0.4 | |
| P / Tangible Book | · | 1.3 | 1.3 | · | · | 0.8 | 27.3 | |
| P / Cash Flow | · | · | · | -7.3 | · | · | · | |
| Earnings Yield | · | -236.9% | -77.3% | -34.1% | · | -110.1% | -458.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Revenue | $1M | $16M | · | · |
| Operating Margin % | -1401.1% | -7.2% | · | · |
| Net Income | $-13M | $-369.6K | $-15M | $-21M |
| Diluted EPS | $-3.06 | $-0.23 | $-18.62 | $-0.02 |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Current Ratio | 27.8 | 3.6 | 3.4 | · |
| Quick Ratio | 27.3 | 3.4 | 3.3 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 23 filers · $8.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
23
Value held
$8.6M
New positions
6
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (0 vs prior Q) | 3 (-4 vs prior Q) | 6 (+1 vs prior Q) | 2 (+1 vs prior Q) | +236K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $3,825,183 | 875,328 | 44.59% | Shares |
| AdvisorShares Investments LLC | $1,105,212 | 252,909 | 12.88% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $758,143 | 173,488 | 8.84% | Shares |
| Shay Capital LLC | $680,942 | 155,822 | 7.94% | Shares |
| Balyasny Asset Management L.P. | $621,536 | 142,228 | 7.24% | Shares |
| CITADEL ADVISORS LLC | $317,083 | 72,559 | 3.70% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $216,384 | 49,516 | 2.52% | Shares |
| Ikarian Capital, LLC | $207,326 | 47,443 | 2.42% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $147,732 | 33,806 | 1.72% | Shares |
| ADAR1 Capital Management, LLC | $131,100 | 30,000 | 1.53% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $111,435 | 25,500 | 1.30% | Shares |
| XTX Topco Ltd | $100,899 | 23,089 | 1.18% | Shares |
| VANGUARD GROUP INC | $81,286 | 20,950 | 0.95% | Shares |
| JANE STREET GROUP, LLC | $65,126 | 14,903 | 0.76% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $61,180 | 14,000 | 0.71% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $49,040 | 11,222 | 0.57% | Shares |
| NORTHERN TRUST CORP | $46,366 | 10,610 | 0.54% | Shares |
| Merck & Co., Inc. | $43,818 | 10,027 | 0.51% | Shares |
| UBS Group AG | $9,251 | 2,117 | 0.11% | Shares |
| MORGAN STANLEY | $254 | 58 | 0.00% | Shares |
| FNY Investment Advisers, LLC | $115 | 26,500 | 0.00% | Shares |
| HRT FINANCIAL LP | $99 | 22,865 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $13 | 3 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP, Weston Nichols ×6 filings | Dec. 29, 2025 | 16.30% | Amendment | · | SEC |
| Apeiron Investment Group Ltd., Apeiron Presight Capital Fund II, L.P., Presight Capital Management I, L.L.C., Fabian Hansen, Christian Angermayer ×3 filings | Jan. 28, 2025 | 4.50% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 5 insiders · 1 officers · 5 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Spyros Papapetropoulos | President and CEO | Aug. 27, 2025 A | · | 0 | 0 | $0 |
| Peter Miles Winston Davies | Director | Jan. 20, 2026 A | · | 0 | 0 | $0 |
| David Ian Wilson | Director | Jan. 20, 2026 A | · | 0 | 0 | $0 |
| Jane Ryan | Director | Jan. 20, 2026 A | · | 0 | 0 | $0 |
| Alan Fisher | Director | Jan. 20, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
NEUP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 6 analysts
SELL
Median target
$7.00
+101.7%
0 0.0%
Strong Buy
0 0.0%
Buy
3 50.0%
Hold
1 16.7%
Sell
2 33.3%
Strong Sell
12-Month Price Target
1 analysts · 2026-05-17Mean target $7.00 +101.7%
Low$7.00
Mean$7.00
High$7.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NEUP | $24M | -1.4 | -92.5% | -1145.7% | -49.5% | · |
| PPCB | $5M | -0.1 | · | · | -190.0% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-K filed Sep 18, 2026